62 filings
6-K
SLN
Silence Therapeutics Plc
17 May 24
Current report (foreign)
5:04pm
6-K
SLN
Silence Therapeutics Plc
16 May 24
Current report (foreign)
2:21pm
6-K
SLN
Silence Therapeutics Plc
1 May 24
Current report (foreign)
4:37pm
6-K
SLN
Silence Therapeutics Plc
29 Apr 24
Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
8:36am
6-K
SLN
Silence Therapeutics Plc
15 Apr 24
Current report (foreign)
7:00am
6-K
ourx 3owa7
13 Mar 24
Current report (foreign)
7:10am
6-K
pviflw7
23 Feb 24
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca
8:12am
6-K
vtuv4
6 Feb 24
Securities Purchase Agreement
12:00am
6-K
i3r473c
1 Dec 23
Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
7:00am
6-K
7uizhd0 ykeg
14 Nov 23
Current report (foreign)
12:00am
6-K
ut1w1d1 hzz3ftkq
1 Nov 23
Current report (foreign)
7:00am
6-K/A
iyfnugg32fb
29 Aug 23
Current report (foreign) (amended)
4:01pm
6-K
ynxal 707au
16 Aug 23
Current report (foreign)
7:00am
6-K
yn2 94iqxyy
11 Jul 23
Silence Therapeutics Achieves $4 Million in Research Milestone Payments from Hansoh Pharma Collaboration
7:00am
6-K
mvsrm4
3 Jul 23
Current report (foreign)
7:30am
6-K
m7mubuod08 8p
16 May 23
Current report (foreign)
4:01pm
6-K
raoz062 pv
4 May 23
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration
7:41am
6-K
f4dkmuj3f1eu
1 May 23
Current report (foreign)
7:31am
6-K
si1 wlb9b
27 Apr 23
Current report (foreign)
4:31pm
6-K
g2gt3
28 Mar 23
Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Development
8:00am